Article type
Abstract
Background: Systematic reviews of etiology and risk are important in public health to inform resource allocation and strategies for disease prevention. Existing recommendations for the conduct of these reviews are incomplete or contradictory. The JBI Aetiology and Risk Methodology Group is a collaborative, multidisciplinary group of experts tasked with formulating and maintaining the methodology used in systematic reviews of etiology and risk research for JBI.
Objectives: To introduce the group's structure; detail plans for updating JBI methodological guidance; discuss the advantages and challenges of multidisciplinary, international collaborative work; and underscore the importance of engaging with various stakeholders possessing relevant expertise. We will also share the initial findings from our scoping review of existing guidance for conducting systematic reviews of etiology and risk, which serve as a foundation for our ongoing efforts.
Methods: The JBI Aetiology and Risk Methodology Group is responsible for formulating and maintaining the corresponding chapter in the JBI Manual for Evidence Synthesis. The group's activities are guided by an ongoing scoping review of recommendations in this field, supplemented by cross-sectional studies examining common pitfalls associated with these reviews. Membership comprises methodologists and healthcare professionals with expertise in evidence synthesis. The group convenes every 6 weeks, and members also allocate time for undertaking research and writing methodological guidance. This period of dedicated effort is crucial for the effective development of methodological guidance for systematic reviews of etiology and risk.
Results: The JBI Aetiology and Risk Methodology Group has made advances elucidating key concepts and processes in reviews of this nature. Current papers cover essential topics such as understanding causal models and risk factors, implementing different types of meta-analyses, and ensuring appropriate use of subgroup analyses. Furthermore, we share insights into the highlights and challenges of establishing and collaborating within such a group, all aimed at enhancing the evidence that informs policies and guidelines in public health.
Conclusions: The JBI Aetiology and Risk Methodology Group is a dynamic collaboration dedicated to the update of methods for systematic reviews of etiology and risk, which may serve as a template for other groups working together to advance methodology in synthesis.
Objectives: To introduce the group's structure; detail plans for updating JBI methodological guidance; discuss the advantages and challenges of multidisciplinary, international collaborative work; and underscore the importance of engaging with various stakeholders possessing relevant expertise. We will also share the initial findings from our scoping review of existing guidance for conducting systematic reviews of etiology and risk, which serve as a foundation for our ongoing efforts.
Methods: The JBI Aetiology and Risk Methodology Group is responsible for formulating and maintaining the corresponding chapter in the JBI Manual for Evidence Synthesis. The group's activities are guided by an ongoing scoping review of recommendations in this field, supplemented by cross-sectional studies examining common pitfalls associated with these reviews. Membership comprises methodologists and healthcare professionals with expertise in evidence synthesis. The group convenes every 6 weeks, and members also allocate time for undertaking research and writing methodological guidance. This period of dedicated effort is crucial for the effective development of methodological guidance for systematic reviews of etiology and risk.
Results: The JBI Aetiology and Risk Methodology Group has made advances elucidating key concepts and processes in reviews of this nature. Current papers cover essential topics such as understanding causal models and risk factors, implementing different types of meta-analyses, and ensuring appropriate use of subgroup analyses. Furthermore, we share insights into the highlights and challenges of establishing and collaborating within such a group, all aimed at enhancing the evidence that informs policies and guidelines in public health.
Conclusions: The JBI Aetiology and Risk Methodology Group is a dynamic collaboration dedicated to the update of methods for systematic reviews of etiology and risk, which may serve as a template for other groups working together to advance methodology in synthesis.